Correa Alicia H, Choi Marcelo R, Gironacci Mariela, Valera María S, Fernández Belisario E
Cátedras de Fisiopatología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, IQUIFIB CONICET, Junín 956 piso 5, 1113 Buenos Aires, Argentina.
Regul Pept. 2007 Jan 10;138(1):26-31. doi: 10.1016/j.regpep.2006.08.001. Epub 2006 Sep 26.
Dopamine (DA) and atrial natriuretic factor (ANF) share a number of physiological effects. We hypothesized that ANF and the renal dopaminergic system could interact and enhance the natriuretic and diuretic effects of the peptide. We have previously reported that the ANF-stimulated DA uptake in renal tubular cells is mediated by the natriuretic peptide type-A receptor (NPR-A). Our aim was to investigate the signaling pathways that mediate ANF effects on renal 3H-DA uptake. Methylene blue (10 microM), an unspecific inhibitor of guanylate cyclase (GC), blunted ANF elicited increase of DA uptake. ODQ (10 microM) a specific inhibitor of soluble GC, did not modify DA uptake and did not reverse ANF-induced increase of DA uptake; then the participation of nitric oxide-dependent pathways must be discarded. The second messenger was the cGMP since the analogous 125 microM 8-Br-cGMP mimicked ANF effects. The specific inhibitor of the protein kinase G (PKG), KT 5823 (1 microM) blocked ANF effects indicating that PKG is involved. We examined if ANF effects on DA uptake were able to modify Na+, K+ -adenosine triphosphatase (Na+, K+ -ATPase) activity. The experiments were designed by means of inhibition of renal DA synthesis by carbidopa and neuronal DA uptake blocked by nomifensine. In these conditions renal Na+, K+ -ATPase activity was increased, in agreement with the decrease of DA availability. When in similar conditions, exogenous DA was added to the incubation medium, the activity of the enzyme tended to decrease, following to the restored availability of DA. The addition of ANF alone had similar effects to the addition of DA on the sodium pump, but when both were added together, the activity of Na(+), K(+)-ATPase was decreased. Moreover, the extraneuronal uptake blocker, hydrocortisone, inhibited the latter effect. In conclusion, ANF stimulates extraneuronal DA uptake in external cortex tissues by activation of NPR-A receptors coupled to GC and it signals through cGMP as second messenger and PKG. Dopamine and ANF may achieve their effects through a common pathway that involves reversible deactivation of renal tubular Na+, K+ -ATPase activity. This mechanism demonstrates a DA-ANF relationship involved in the modulation of both decreased sodium reabsorption and increased natriuresis.
多巴胺(DA)和心房利钠因子(ANF)具有多种生理效应。我们推测,ANF与肾多巴胺能系统可能相互作用,增强该肽的利钠和利尿作用。我们之前曾报道,ANF刺激肾小管细胞摄取DA是由A型利钠肽受体(NPR-A)介导的。我们的目的是研究介导ANF对肾3H-DA摄取作用的信号通路。亚甲蓝(10微摩尔),一种鸟苷酸环化酶(GC)的非特异性抑制剂,减弱了ANF引起的DA摄取增加。ODQ(10微摩尔),一种可溶性GC的特异性抑制剂,未改变DA摄取,也未逆转ANF诱导的DA摄取增加;因此,必须排除一氧化氮依赖性途径的参与。第二信使是环磷酸鸟苷(cGMP),因为类似的125微摩尔8-溴-cGMP模拟了ANF的作用。蛋白激酶G(PKG)的特异性抑制剂KT 5823(1微摩尔)阻断了ANF的作用,表明PKG参与其中。我们研究了ANF对DA摄取的作用是否能够改变钠钾-腺苷三磷酸酶(Na+,K+-ATP酶)的活性。实验通过卡比多巴抑制肾DA合成和诺米芬辛阻断神经元DA摄取来设计。在这些条件下,肾Na+,K+-ATP酶活性增加,这与DA可用性的降低一致。当在类似条件下,将外源性DA添加到孵育培养基中时,随着DA可用性的恢复,该酶的活性趋于降低。单独添加ANF对钠泵的作用与添加DA相似,但当两者一起添加时,Na+,K+-ATP酶的活性降低。此外,非神经元摄取阻断剂氢化可的松抑制了后一种作用。总之,ANF通过激活与GC偶联的NPR-A受体刺激肾皮质组织中非神经元DA的摄取,并通过cGMP作为第二信使和PKG进行信号传导。多巴胺和ANF可能通过涉及肾小管Na+,K+-ATP酶活性可逆失活的共同途径实现其作用。这种机制证明了DA-ANF关系参与了钠重吸收减少和利钠增加的调节。